Clinical trial

Effects of a Multiple Sclerosis Relapse Therapy on Offspring Neurocognitive Development and Behaviour

NCT04832269

StatusUNKNOWN

Study typeOBSERVATIONAL

Start date2020-10-19

PhaseN/A

Study timeline

Study start (actual)2020-10-19Date precision: day

Registry last updated2024-03-06

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Multiple Sclerosisunresolved

Interventions

Exposure to methylprednisolone during pregnancyOTHER

Sponsors & collaborators

Jena University Hospitallead sponsor

Ruhr University of Bochumcollaborator

Interdisciplinary Center of Clinical Research of the Medical Faculty Jenacollaborator

Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germanycollaborator

Mapped research locations

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04832269 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.